DaVita (DVA): are the analysts right?

DaVita · Health Care · ref. ETF XLV · 50 calls · price $234.31
What the company does: DaVita Inc. fournit des services de dialyse rénale pour les patients souffrant d'insuffisance rénale chronique aux États-Unis.
📈 1-year price
$234.31+62.9% over range
Jul 8, 25low $103.87 · high $235.71Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
40% recommend buying · 5 analysts
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.

🎯 Analyst price target on DVA

High target · 1 analyst$235+0.3%
Median target · 5 analysts$205-12.5%
Low target · 1 analyst$194-17.2%
Current price$234.31

🗳️ The analyst consensus

Analyst breakdown · 5 (6 months)
Strong Buy0%
Buy40%
Hold60%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on DVA

Most reliable analysts on DVA (% profitable · 365j · ≥2 calls)
UBS 83% +23.7% 6
B of A Securities 50% -14.1% 2

📊 What $1,000 invested in DaVita would be worth

In short — $1,000 invested in DaVita 10 years ago would be worth $3,192 today, i.e. +12%/yr on average. Best year: 2020 (+56%), worst: 2022 (-34%). Price performance, excluding dividends.

If I'd invested $1,000 in DaVita

InvestmentWorth todayGain
1 years ago$1,488+49%
3 years ago$2,980+198%
5 years ago$1,895+90%
10 years ago$3,192+219%
since inception (1995)$41,392+4039%

Return by year (DaVita)

YearReturn$1,000 invested at year start
2026 (YTD)+96%$1,958 (+96%)
2025-24%$1,488 (+49%)
2024+43%$2,124 (+112%)
2023+40%$2,980 (+198%)
2022-34%$1,956 (+96%)
2021-3%$1,895 (+90%)
2020+56%$2,965 (+197%)
2019+46%$4,323 (+332%)
2018-29%$3,079 (+208%)
2017+13%$3,465 (+247%)
2016-8%$3,192 (+219%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on DVA

TD Cowen
May 11, 26
■ Hold neutral · not a buy · 🎯$201
Price at call : $200.54 — gap to target +0%
Today : $234.31 — gap to target -14%
🎯 on DVA : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : May 11, 27
■ Hold neutral · not a buy · 🎯$205
Price at call : $198.93 — gap to target +3%
Today : $234.31 — gap to target -13%
🎯 on DVA : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : May 8, 27
Barclays
May 8, 26
■ Equal-Weight neutral · not a buy · 🎯$194
Price at call : $198.93 — gap to target -2%
Today : $234.31 — gap to target -17%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : May 8, 27
UBS
May 8, 26
▲ Buy · 🎯$235
Price at call : $198.65 — upside +18%
Today : $234.31 — upside +0%
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : May 8, 27
▲ Buy · 🎯$220
Price at call : $193.88 — upside +13%
Today : $234.31 — upside -6%
🎯 on DVA : 100% (1 call matured) · 📊 on Health : 53.3% · +4.4% (289 calls)
in progress (365j)
matures : May 6, 27
UBS
Feb 4, 26
▲ Buy · 🎯$190
Price at call : $149.22 — upside +27%
Today : $234.31 — upside -19%
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Feb 4, 27
Barclays
Feb 3, 26
■ Equal-Weight neutral · not a buy · 🎯$158
Price at call : $134.73 — gap to target +17%
Today : $234.31 — gap to target -33%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Feb 3, 27
TD Cowen
Nov 3, 25
■ Hold neutral · not a buy · 🎯$133
Price at call : $119.97 — gap to target +11%
Today : $234.31 — gap to target -43%
🎯 on DVA : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Nov 3, 26
Barclays
Oct 30, 25
■ Equal-Weight neutral · not a buy · 🎯$143
Price at call : $119.02 — gap to target +20%
Today : $234.31 — gap to target -39%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Oct 30, 26
Barclays
Oct 9, 25
■ Equal-Weight neutral · not a buy · 🎯$149
Price at call : $126.38 — gap to target +18%
Today : $234.31 — gap to target -36%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Oct 9, 26
▼ Underperform · 🎯$140
Price at call : $133.24 — upside +5%
Today : $234.31 — upside -40%
🎯 on DVA : 50% (2 calls matureds) · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Sep 10, 26
Barclays
Aug 7, 25
■ Equal-Weight neutral · not a buy · 🎯$160
Price at call : $127.69 — gap to target +25%
Today : $234.31 — gap to target -32%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Aug 7, 26
■ Hold neutral · not a buy · 🎯$164
Price at call : $144.96 — gap to target +13%
Today : $234.31 — gap to target -30%
🎯 on DVA : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : May 19, 26
Barclays
Feb 18, 25
■ Equal-Weight neutral · not a buy · 🎯$169
Price at call : $155.05 — gap to target +9%
Today : $234.31 — gap to target -28%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Feb 18, 26
Barclays
Oct 31, 24
■ Equal-Weight neutral · not a buy · 🎯$164
Price at call : $141.59 — gap to target +16%
Today : $234.31 — gap to target -30%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Oct 31, 25
■ Hold neutral · not a buy · 🎯$175
Price at call : $157.54 — gap to target +11%
Today : $234.31 — gap to target -25%
🎯 on DVA : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Oct 7, 25
■ Hold neutral · not a buy · 🎯$165
Price at call : $150.6 — gap to target +10%
Today : $234.31 — gap to target -30%
🎯 on DVA : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Aug 20, 25
UBS
Aug 8, 24
▲ Buy · 🎯$175
Price at call : $140.3 — upside +25%
Today : $234.31 — upside -25%
Expected +25% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
-8.0%
stock -8% · XLV -13%
▼ Underperform · 🎯$145
Price at call : $138.88 — upside +4%
Today : $234.31 — upside -38%
Expected +4% · Actual -7% · Reason (≤ −15%) : ✗ No
🎯 on DVA : 50% (2 calls matureds) · 📊 on Health : 48.6% · +2.3% (352 calls)
+6.8%
stock -7% · XLV -13%
TD Cowen
Jul 24, 24
■ Hold neutral · not a buy · 🎯$150
Price at call : $142.5 — gap to target +5%
Today : $234.31 — gap to target -36%
🎯 on DVA : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Jul 24, 25
■ Hold neutral · not a buy · 🎯$150
Price at call : $136.48 — gap to target +10%
Today : $234.31 — gap to target -36%
🎯 on DVA : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : May 15, 25
Barclays
May 6, 24
■ Equal-Weight neutral · not a buy · 🎯$150
Price at call : $137.69 — gap to target +9%
Today : $234.31 — gap to target -36%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : May 6, 25
Barclays
Mar 6, 24
■ Equal-Weight neutral · not a buy · 🎯$133
Price at call : $134.08 — gap to target -1%
Today : $234.31 — gap to target -43%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Mar 6, 25
■ Hold neutral · not a buy · 🎯$135
Price at call : $123 — gap to target +10%
Today : $234.31 — gap to target -42%
🎯 on DVA : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Feb 19, 25
UBS
Feb 15, 24
▲ Buy · 🎯$145
Price at call : $122.22 — upside +19%
Today : $234.31 — upside -38%
Expected +19% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
+26.9%
stock +27% · XLV -1%
UBS
Feb 14, 24
▲ Buy · 🎯$134
Price at call : $119.87 — upside +12%
Today : $234.31 — upside -43%
Expected +12% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
+31.3%
stock +31% · XLV -0%
■ Hold neutral · not a buy · 🎯$130
Price at call : $123.41 — gap to target +5%
Today : $234.31 — gap to target -45%
🎯 on DVA : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Feb 13, 25
UBS
Nov 17, 23
▲ Buy · 🎯$113
Price at call : $97.53 — upside +16%
Today : $234.31 — upside -52%
Expected +16% · Actual +61% · Reason (≥ +15%) : ✓ Yes
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
+61.4%
stock +61% · XLV +10%
■ Hold neutral · not a buy · 🎯$104
Price at call : $73.79 — gap to target +41%
Today : $234.31 — gap to target -56%
🎯 on DVA : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Oct 10, 24
UBS
Aug 7, 23
▲ Buy · 🎯$142
Price at call : $112.68 — upside +26%
Today : $234.31 — upside -39%
Expected +26% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
+21.6%
stock +22% · XLV +10%
■ Hold neutral · not a buy · 🎯$115
Price at call : $103.74 — gap to target +11%
Today : $234.31 — gap to target -51%
🎯 on DVA : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Jul 12, 24
Bernstein
May 15, 23
■ Market Perform neutral · not a buy · 🎯$100
Price at call : $96.86 — gap to target +3%
Today : $234.31 — gap to target -57%
🎯 on DVA : no call matured yet · 📊 on Health : 55.6% · +5.7% (63 calls)
in progress (365j)
matures : May 14, 24
■ Hold neutral · not a buy · 🎯$113
Price at call : $99.27 — gap to target +14%
Today : $234.31 — gap to target -52%
🎯 on DVA : 100% (1 call matured) · 📊 on Health : 53.3% · +4.4% (289 calls)
in progress (365j)
matures : May 8, 24
■ Hold neutral · not a buy · 🎯$100
Price at call : $100.72 — gap to target -1%
Today : $234.31 — gap to target -57%
🎯 on DVA : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : May 8, 24
TD Cowen
May 9, 23
■ Market Perform neutral · not a buy · 🎯$98
Price at call : $100.72 — gap to target -3%
Today : $234.31 — gap to target -58%
🎯 on DVA : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : May 8, 24
▼ Underperform · 🎯$96
Price at call : $100.72 — upside -5%
Today : $234.31 — upside -59%
Expected -5% · Actual +35% · Reason (≤ −15%) : ✗ No
🎯 on DVA : 50% (2 calls matureds) · 📊 on Health : 48.6% · +2.3% (352 calls)
-34.9%
stock +35% · XLV +7%
Cowen & Co.
Feb 23, 23
▲ Outperform · 🎯$90
Price at call : $82.31 — upside +9%
Today : $234.31 — upside -62%
Expected +9% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on DVA : 100% (1 call matured) · 📊 unranked overall
+51.8%
stock +52% · XLV +14%
■ Hold neutral · not a buy · 🎯$90
Price at call : $82.87 — gap to target +9%
Today : $234.31 — gap to target -62%
🎯 on DVA : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Feb 23, 24
■ Hold neutral · not a buy · 🎯$75
Price at call : $69.87 — gap to target +7%
Today : $234.31 — gap to target -68%
🎯 on DVA : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Oct 31, 23
Barclays
Oct 31, 22
■ Equal-Weight neutral · not a buy · 🎯$81
Price at call : $73.01 — gap to target +11%
Today : $234.31 — gap to target -65%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Oct 31, 23
UBS
Oct 31, 22
■ Neutral neutral · not a buy · 🎯$74
Price at call : $73.01 — gap to target +1%
Today : $234.31 — gap to target -68%
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Oct 31, 23
UBS
Aug 19, 22
▲ Buy · 🎯$117
Price at call : $93.21 — upside +26%
Today : $234.31 — upside -50%
Expected +26% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on DVA : 83% (6 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
+9.3%
stock +9% · XLV +1%
Barclays
Aug 4, 22
■ Equal-Weight neutral · not a buy · 🎯$103
Price at call : $85.31 — gap to target +21%
Today : $234.31 — gap to target -56%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Aug 4, 23
▲ Buy · 🎯$97
Price at call : $84.8 — upside +14%
Today : $234.31 — upside -59%
Expected +14% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on DVA : 100% (1 call matured) · 📊 on Health : 53.3% · +4.4% (289 calls)
+19.8%
stock +20% · XLV +1%
■ Hold neutral · not a buy · 🎯$90
Price at call : $80.58 — gap to target +12%
Today : $234.31 — gap to target -62%
🎯 on DVA : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Jun 22, 23
■ Hold neutral · not a buy · 🎯$125
Price at call : $111.28 — gap to target +12%
Today : $234.31 — gap to target -47%
🎯 on DVA : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Jan 5, 23
RBC Capital
Oct 29, 21
■ Sector Perform neutral · not a buy · 🎯$111
Price at call : $103.24 — gap to target +8%
Today : $234.31 — gap to target -53%
🎯 on DVA : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Oct 29, 22
■ Hold neutral · not a buy · 🎯$125
Price at call : $111.47 — gap to target +12%
Today : $234.31 — gap to target -47%
🎯 on DVA : no call matured yet · 📊 on Health : 50% · +2.1% (248 calls)
in progress (365j)
matures : Oct 13, 22
Cowen & Co.
Sep 10, 21
■ Market Perform neutral · not a buy · 🎯$145
Price at call : $123.05 — gap to target +18%
Today : $234.31 — gap to target -38%
🎯 on DVA : 100% (1 call matured) · 📊 unranked overall
in progress (365j)
matures : Sep 10, 22
Barclays
Aug 12, 21
■ Equal-Weight neutral · not a buy · 🎯$146
Price at call : $131.27 — gap to target +11%
Today : $234.31 — gap to target -38%
🎯 on DVA : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Aug 12, 22
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)